High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell lines.
Oncotarget
; 9(40): 26064-26071, 2018 May 25.
Article
in En
| MEDLINE
| ID: mdl-29899842
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Oncotarget
Year:
2018
Type:
Article
Affiliation country:
Canada